| Item | Value |
|---|---|
| DrugBank ID | DB00570 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 28 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Kaposi’s sarcoma (disease) | TxGNN Knowledge Graph |
| 2 | B-cell neoplasm | TxGNN Knowledge Graph |
| 3 | mantle cell lymphoma | TxGNN Knowledge Graph |
| 4 | testicular cancer | TxGNN Knowledge Graph |
| 5 | lymphosarcoma | TxGNN Knowledge Graph |
| 6 | primary cutaneous T-cell lymphoma | TxGNN Knowledge Graph |
| 7 | female breast carcinoma | TxGNN Knowledge Graph |
| 8 | granulomatous slack skin disease | TxGNN Knowledge Graph |
| 9 | obsolete Hodgkin’s granuloma | TxGNN Knowledge Graph |
| 10 | seminoma | TxGNN Knowledge Graph |
| 11 | testicular germ cell tumor | TxGNN Knowledge Graph |
| 12 | Hodgkins lymphoma | TxGNN Knowledge Graph |
| 13 | classic Hodgkin lymphoma, lymphocyte-rich type | TxGNN Knowledge Graph |
| 14 | spermatocytic seminoma | TxGNN Knowledge Graph |
| 15 | Langerhans cell histiocytosis | TxGNN Knowledge Graph |
| 16 | folliculotropic mycosis fungoides | TxGNN Knowledge Graph |
| 17 | lymphoma | TxGNN Knowledge Graph |
| 18 | testicular teratoma | TxGNN Knowledge Graph |
| 19 | testicular seminoma | TxGNN Knowledge Graph |
| 20 | Hodgkin’s paragranuloma | TxGNN Knowledge Graph |
| 21 | mycosis fungoides and variants | TxGNN Knowledge Graph |
| 22 | lymphoma, non-Hodgkin, familial | TxGNN Knowledge Graph |
| 23 | letterer-Siwe disease | TxGNN Knowledge Graph |
| 24 | localized pagetoid reticulosis | TxGNN Knowledge Graph |
| 25 | yolk sac tumor | TxGNN Knowledge Graph |
| 26 | non-Hodgkin lymphoma | TxGNN Knowledge Graph |
| 27 | classic Hodgkin lymphoma | TxGNN Knowledge Graph |
| 28 | gestational trophoblastic neoplasm | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.